NCI Advisors Approve Plan For Repository For Prostate Cancer Issue Specimens
In Brief: Nabel To Direct Vaccine Research Center; Former NIH Director Robert Marston Is Dead
Science Policy: NCAB Opposes Law Making Data Available Under FOIA; Individuals Encouraged To Send comments To OMB
Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House
Mack, to Retire, Calls Budget Proposal an “Act of Retreat”
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









